Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pleckstrin homology domain-containing family B member 1 (PLEKHB1, also known as evectin-1 and various aliases) is a single-pass transmembrane protein containing an N-terminal pleckstrin homology domain, predominantly expressed in the mammalian brain and sensory tissues, especially the retina[1][3]. Its best-studied homologues and its vesicular localization suggest a role in intracellular membrane trafficking—specifically, protein transport involving recycling endosomes and the trans-Golgi network, possibly through binding to phosphatidylserine and unconventional myosins[1][2]. While its precise physiological function remains unclear, PLEKHB1 is implicated as a molecular regulator in neural health, with deregulation (especially decreased levels) linked experimentally to the onset of neurodegenerative changes in motor neurons in ALS mouse models[1]. It is not a well-established drug target, and no direct drugs or therapeutic mechanisms are currently identified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pleckstrin homology domain-containing family B member 1 (PLEKHB1).